Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers

Jon R. Wiener, Christopher Windham, Veronica C. Estrella, Nila U. Parikh, Peter F. Thall, Michael T. Deavers, Robert C. Bast, Gordon Mills, Gary E. Gallick

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

Objective. The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers. Methods. Western analysis and immune complex kinase assays were performed on a panel of human ovarian cancer cell lines and normal ovarian epithelial cell cultures, and immunohistochemical analysis for Src and activated Src were performed on a panel of late-stage human ovarian tumors. Results and conclusions. Src is overexpressed and activated in a majority of late-stage ovarian tumors as well as in a panel of cultured malignant human ovarian epithelium grown in vitro, but not in normal ovarian epithelium (NOE) or immortalized NOE. Src overexpression was found to be frequently, but not always, associated with HER-2/neu overexpression, but no statistical association between Src and Her-2/neu overexpression could be demonstrated.

Original languageEnglish (US)
Pages (from-to)73-79
Number of pages7
JournalGynecologic Oncology
Volume88
Issue number1
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

src-Family Kinases
Ovarian Neoplasms
Epithelium
Antigen-Antibody Complex
Neoplasms
Phosphotransferases
Cell Culture Techniques
Epithelial Cells
Cell Line

Keywords

  • Immuno-histochemistry
  • Monoclonal antibody
  • Ovarian cancer
  • Src
  • Tyrosine kinase
  • Yes

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Wiener, J. R., Windham, C., Estrella, V. C., Parikh, N. U., Thall, P. F., Deavers, M. T., ... Gallick, G. E. (2003). Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecologic Oncology, 88(1), 73-79. https://doi.org/10.1006/gyno.2002.6851

Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. / Wiener, Jon R.; Windham, Christopher; Estrella, Veronica C.; Parikh, Nila U.; Thall, Peter F.; Deavers, Michael T.; Bast, Robert C.; Mills, Gordon; Gallick, Gary E.

In: Gynecologic Oncology, Vol. 88, No. 1, 01.01.2003, p. 73-79.

Research output: Contribution to journalArticle

Wiener, JR, Windham, C, Estrella, VC, Parikh, NU, Thall, PF, Deavers, MT, Bast, RC, Mills, G & Gallick, GE 2003, 'Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers', Gynecologic Oncology, vol. 88, no. 1, pp. 73-79. https://doi.org/10.1006/gyno.2002.6851
Wiener JR, Windham C, Estrella VC, Parikh NU, Thall PF, Deavers MT et al. Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecologic Oncology. 2003 Jan 1;88(1):73-79. https://doi.org/10.1006/gyno.2002.6851
Wiener, Jon R. ; Windham, Christopher ; Estrella, Veronica C. ; Parikh, Nila U. ; Thall, Peter F. ; Deavers, Michael T. ; Bast, Robert C. ; Mills, Gordon ; Gallick, Gary E. / Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. In: Gynecologic Oncology. 2003 ; Vol. 88, No. 1. pp. 73-79.
@article{7794e82d1ade4c73b8f0360e5bb91745,
title = "Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers",
abstract = "Objective. The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers. Methods. Western analysis and immune complex kinase assays were performed on a panel of human ovarian cancer cell lines and normal ovarian epithelial cell cultures, and immunohistochemical analysis for Src and activated Src were performed on a panel of late-stage human ovarian tumors. Results and conclusions. Src is overexpressed and activated in a majority of late-stage ovarian tumors as well as in a panel of cultured malignant human ovarian epithelium grown in vitro, but not in normal ovarian epithelium (NOE) or immortalized NOE. Src overexpression was found to be frequently, but not always, associated with HER-2/neu overexpression, but no statistical association between Src and Her-2/neu overexpression could be demonstrated.",
keywords = "Immuno-histochemistry, Monoclonal antibody, Ovarian cancer, Src, Tyrosine kinase, Yes",
author = "Wiener, {Jon R.} and Christopher Windham and Estrella, {Veronica C.} and Parikh, {Nila U.} and Thall, {Peter F.} and Deavers, {Michael T.} and Bast, {Robert C.} and Gordon Mills and Gallick, {Gary E.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1006/gyno.2002.6851",
language = "English (US)",
volume = "88",
pages = "73--79",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers

AU - Wiener, Jon R.

AU - Windham, Christopher

AU - Estrella, Veronica C.

AU - Parikh, Nila U.

AU - Thall, Peter F.

AU - Deavers, Michael T.

AU - Bast, Robert C.

AU - Mills, Gordon

AU - Gallick, Gary E.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Objective. The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers. Methods. Western analysis and immune complex kinase assays were performed on a panel of human ovarian cancer cell lines and normal ovarian epithelial cell cultures, and immunohistochemical analysis for Src and activated Src were performed on a panel of late-stage human ovarian tumors. Results and conclusions. Src is overexpressed and activated in a majority of late-stage ovarian tumors as well as in a panel of cultured malignant human ovarian epithelium grown in vitro, but not in normal ovarian epithelium (NOE) or immortalized NOE. Src overexpression was found to be frequently, but not always, associated with HER-2/neu overexpression, but no statistical association between Src and Her-2/neu overexpression could be demonstrated.

AB - Objective. The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers. Methods. Western analysis and immune complex kinase assays were performed on a panel of human ovarian cancer cell lines and normal ovarian epithelial cell cultures, and immunohistochemical analysis for Src and activated Src were performed on a panel of late-stage human ovarian tumors. Results and conclusions. Src is overexpressed and activated in a majority of late-stage ovarian tumors as well as in a panel of cultured malignant human ovarian epithelium grown in vitro, but not in normal ovarian epithelium (NOE) or immortalized NOE. Src overexpression was found to be frequently, but not always, associated with HER-2/neu overexpression, but no statistical association between Src and Her-2/neu overexpression could be demonstrated.

KW - Immuno-histochemistry

KW - Monoclonal antibody

KW - Ovarian cancer

KW - Src

KW - Tyrosine kinase

KW - Yes

UR - http://www.scopus.com/inward/record.url?scp=0037229627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037229627&partnerID=8YFLogxK

U2 - 10.1006/gyno.2002.6851

DO - 10.1006/gyno.2002.6851

M3 - Article

VL - 88

SP - 73

EP - 79

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -